Treatment data from the Brazilian fibromyalgia registry (EpiFibro)

Abstract Background EpiFibro (Brazilian Epidemiological Study of Fibromyalgia) was created to study patients with fibromyalgia (FM). Patients were included since 2011 according to the classification criteria for FM of the American College of Rheumatology of 1990 (ACR1990). Objective To analyze the t...

Full description

Bibliographic Details
Main Authors: Marcos Renato de Assis, Eduardo dos Santos Paiva, Milton Helfenstein, Roberto Ezequiel Heymann, Daniel Feldman Pollak, Jose Roberto Provenza, Aline Ranzolin, Marcelo Cruz Rezende, Luiz Severiano Ribeiro, Eduardo José R. Souza, José Eduardo Martinez
Format: Article
Language:English
Published: BMC 2020-01-01
Series:Advances in Rheumatology
Subjects:
Online Access:https://doi.org/10.1186/s42358-019-0108-2
id doaj-94f7d3408b9549ad9c62d1ccda246ad2
record_format Article
spelling doaj-94f7d3408b9549ad9c62d1ccda246ad22021-01-24T12:43:01ZengBMCAdvances in Rheumatology2523-31062020-01-016011510.1186/s42358-019-0108-2Treatment data from the Brazilian fibromyalgia registry (EpiFibro)Marcos Renato de Assis0Eduardo dos Santos Paiva1Milton Helfenstein2Roberto Ezequiel Heymann3Daniel Feldman Pollak4Jose Roberto Provenza5Aline Ranzolin6Marcelo Cruz Rezende7Luiz Severiano Ribeiro8Eduardo José R. Souza9José Eduardo Martinez10Faculdade de Medicina de Marília (FAMEMA)Sociedade Brasileira de Reumatologia (SBR)Sociedade Brasileira de Reumatologia (SBR)Sociedade Brasileira de Reumatologia (SBR)Sociedade Brasileira de Reumatologia (SBR)Sociedade Brasileira de Reumatologia (SBR)Sociedade Brasileira de Reumatologia (SBR)Sociedade Brasileira de Reumatologia (SBR)Sociedade Brasileira de Reumatologia (SBR)Sociedade Brasileira de Reumatologia (SBR)Sociedade Brasileira de Reumatologia (SBR)Abstract Background EpiFibro (Brazilian Epidemiological Study of Fibromyalgia) was created to study patients with fibromyalgia (FM). Patients were included since 2011 according to the classification criteria for FM of the American College of Rheumatology of 1990 (ACR1990). Objective To analyze the therapeutic measures prescribed by Brazilian physicians. Materials and methods Cross-sectional study of a multicenter cohort. The therapeutic measures were described using descriptive statistics. Results We analyzed 456 patients who had complete data in the registry. The mean age was 54.0 ± 11.9 years; 448 were women (98.2%). Almost all patients (98.4%) used medications, 62.7% received health education, and less than half reported practicing physical exercise; these modalities were often used in combination. Most patients who practiced exercises practiced aerobic exercise only, and a significant portion of patients combined it with flexibility exercises. The most commonly used medication was amitriptyline, followed by cyclobenzaprine, and a minority used medication specifically approved for FM, such as duloxetine and pregabalin, either alone or in combination. Combinations of two or three medications were observed, with the combination of fluoxetine and amitriptyline being the most frequent (18.8%). Conclusion In this evaluation of the care of patients with FM in Brazil, it was found that the majority of patients are treated with a combination of pharmacological measures. Non-pharmacological methods are underused, with aerobic exercise being the most commonly practiced exercise type. The most commonly prescribed single drug was amitriptyline, and the most commonly prescribed combination was fluoxetine and amitriptyline. Drugs specifically approved for FM are seldom prescribed.https://doi.org/10.1186/s42358-019-0108-2FibromyalgiaTreatmentRegistriesChronic pain
collection DOAJ
language English
format Article
sources DOAJ
author Marcos Renato de Assis
Eduardo dos Santos Paiva
Milton Helfenstein
Roberto Ezequiel Heymann
Daniel Feldman Pollak
Jose Roberto Provenza
Aline Ranzolin
Marcelo Cruz Rezende
Luiz Severiano Ribeiro
Eduardo José R. Souza
José Eduardo Martinez
spellingShingle Marcos Renato de Assis
Eduardo dos Santos Paiva
Milton Helfenstein
Roberto Ezequiel Heymann
Daniel Feldman Pollak
Jose Roberto Provenza
Aline Ranzolin
Marcelo Cruz Rezende
Luiz Severiano Ribeiro
Eduardo José R. Souza
José Eduardo Martinez
Treatment data from the Brazilian fibromyalgia registry (EpiFibro)
Advances in Rheumatology
Fibromyalgia
Treatment
Registries
Chronic pain
author_facet Marcos Renato de Assis
Eduardo dos Santos Paiva
Milton Helfenstein
Roberto Ezequiel Heymann
Daniel Feldman Pollak
Jose Roberto Provenza
Aline Ranzolin
Marcelo Cruz Rezende
Luiz Severiano Ribeiro
Eduardo José R. Souza
José Eduardo Martinez
author_sort Marcos Renato de Assis
title Treatment data from the Brazilian fibromyalgia registry (EpiFibro)
title_short Treatment data from the Brazilian fibromyalgia registry (EpiFibro)
title_full Treatment data from the Brazilian fibromyalgia registry (EpiFibro)
title_fullStr Treatment data from the Brazilian fibromyalgia registry (EpiFibro)
title_full_unstemmed Treatment data from the Brazilian fibromyalgia registry (EpiFibro)
title_sort treatment data from the brazilian fibromyalgia registry (epifibro)
publisher BMC
series Advances in Rheumatology
issn 2523-3106
publishDate 2020-01-01
description Abstract Background EpiFibro (Brazilian Epidemiological Study of Fibromyalgia) was created to study patients with fibromyalgia (FM). Patients were included since 2011 according to the classification criteria for FM of the American College of Rheumatology of 1990 (ACR1990). Objective To analyze the therapeutic measures prescribed by Brazilian physicians. Materials and methods Cross-sectional study of a multicenter cohort. The therapeutic measures were described using descriptive statistics. Results We analyzed 456 patients who had complete data in the registry. The mean age was 54.0 ± 11.9 years; 448 were women (98.2%). Almost all patients (98.4%) used medications, 62.7% received health education, and less than half reported practicing physical exercise; these modalities were often used in combination. Most patients who practiced exercises practiced aerobic exercise only, and a significant portion of patients combined it with flexibility exercises. The most commonly used medication was amitriptyline, followed by cyclobenzaprine, and a minority used medication specifically approved for FM, such as duloxetine and pregabalin, either alone or in combination. Combinations of two or three medications were observed, with the combination of fluoxetine and amitriptyline being the most frequent (18.8%). Conclusion In this evaluation of the care of patients with FM in Brazil, it was found that the majority of patients are treated with a combination of pharmacological measures. Non-pharmacological methods are underused, with aerobic exercise being the most commonly practiced exercise type. The most commonly prescribed single drug was amitriptyline, and the most commonly prescribed combination was fluoxetine and amitriptyline. Drugs specifically approved for FM are seldom prescribed.
topic Fibromyalgia
Treatment
Registries
Chronic pain
url https://doi.org/10.1186/s42358-019-0108-2
work_keys_str_mv AT marcosrenatodeassis treatmentdatafromthebrazilianfibromyalgiaregistryepifibro
AT eduardodossantospaiva treatmentdatafromthebrazilianfibromyalgiaregistryepifibro
AT miltonhelfenstein treatmentdatafromthebrazilianfibromyalgiaregistryepifibro
AT robertoezequielheymann treatmentdatafromthebrazilianfibromyalgiaregistryepifibro
AT danielfeldmanpollak treatmentdatafromthebrazilianfibromyalgiaregistryepifibro
AT joserobertoprovenza treatmentdatafromthebrazilianfibromyalgiaregistryepifibro
AT alineranzolin treatmentdatafromthebrazilianfibromyalgiaregistryepifibro
AT marcelocruzrezende treatmentdatafromthebrazilianfibromyalgiaregistryepifibro
AT luizseverianoribeiro treatmentdatafromthebrazilianfibromyalgiaregistryepifibro
AT eduardojosersouza treatmentdatafromthebrazilianfibromyalgiaregistryepifibro
AT joseeduardomartinez treatmentdatafromthebrazilianfibromyalgiaregistryepifibro
_version_ 1724325477760368640